This Day On The Street
Continue to site right-arrow
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
TheStreet Open House

Eastern Health Goes Live With NexJ Disease Screening

Enhanced system to manage screening for colorectal cancer, the second leading cause of cancer death in Canada, being deployed in Newfoundland and Labrador

TORONTO, July 23, 2012 /CNW/ - NexJ Systems Inc., (TSX: NXJ) a leading provider of next generation enterprise customer relationship management (CRM) solutions, today announced that Eastern Health, the largest, integrated health authority in Newfoundland and Labrador, has begun use of the NexJ Disease Screening solution for its Colorectal Screening Information and Reporting System project.  This makes Eastern Health the second Canadian healthcare provider to use NexJ Disease Screening for colorectal screening for large populations of patients.

According to the Canadian Cancer Society, colorectal cancer is the second-leading cause of cancer death in Canada.  In 2012 an estimated 23,300 Canadians (13,000 men - 10,300 women) will be diagnosed with colorectal cancer and 9,200 (5,000 men - 4,200 women) will die from it.  On average, 64 Canadians will be diagnosed with colorectal cancer every day and 25 will die from the disease every day. 1

"NexJ Disease Screening is proven to improve wellness within a population as evidenced in Saskatchewan by the Saskatchewan Cancer Agency.  Eastern Health now joins Saskatchewan in use of our solution for their population-based disease surveillance programs which have successfully identified pre-symptomatic individuals with colorectal cancer," said Eric Gombrich, SVP & GM, Health Solutions Group, NexJ Systems. "A significant contributing factor in Saskatchewan's early detection success has been the high participation rate of nearly 50 per cent of the population identified by the Screening Program for Colorectal Cancer. This approach has proven to enable dramatically higher participation than in other initiatives."

NexJ Disease Screening enables proactive, targeted screening for diseases across a population.  Health provider networks use the solution to identify treatable diseases early, enable coordinated action when disease is detected, and analyze results to improve screening programs and public health.

1 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Try it NOW
Only $9.95
Try it NOW
14-Days Free
Try it NOW

Check Out Our Best Services for Investors

Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
Try it NOW
Try it NOW
Try it NOW
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!


DOW 17,712.66 +34.43 0.19%
S&P 500 2,061.02 +4.87 0.24%
NASDAQ 4,891.2190 +27.8570 0.57%

Partners Compare Online Brokers

Free Reports

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs